American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The H4-Index of American Journal of Clinical Oncology-Cancer Clinical Trials is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Efficacy and Safety of Pegylated Filgrastim as Primary Prophylaxis Following Pediatric Dose-intensive Chemotherapy61
Death From Infection Among Patients Living With Cancer42
Cardiac Angiosarcomas24
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma24
The Impact of Patient, Disease, and Social Determinants of Health on Receipt of Nonoperative Management for Patients With Rectal Adenocarcinoma18
Validation of Spanish-Language Surveys Utilized for the Navigator-Assisted Hypofractionation (NAVAH) Program to Aid Hispanic-American Breast Cancer Patients17
Pharmacokinetics-Pharmacodynamics Modeling and Evaluation of Tumor Response to Bortezomib Proteasome Inhibitor in Waldenstrom Macroglobulinemia16
Clinical Outcomes and Safety Profile of Adagrasib in KRAS G12C-Mutated Solid Tumors16
Does Examined Lymph Node Count Influence Survival in Surgically Resected Early‑stage Pulmonary Typical Carcinoid Tumors?14
Nomogram Predicting Grade ≥2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy14
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers14
Short-term ADT and Dose-escalated IMRT in Patients With Intermediate-risk Prostate Cancer12
0.13556790351868